梓橦宫 — Investor Relations & Filings
About 梓橦宫
Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 上海天璇律师事务所关于四川梓橦宫药业股份有限公司2026年第二次临时股东会的法律意见书 | 2026-04-27 | Chinese | |
| 2025年度独立董事述职报告（程志鹏） | 2026-04-27 | Chinese | |
| 2025年度独立董事述职报告（黄元林） | 2026-04-27 | Chinese | |
| 关于召开2025年年度股东会通知公告（提供网络投票） | 2026-04-27 | Chinese | |
| 2025年度内部控制评价报告 | 2026-04-27 | Chinese | |
| 关于2026年董事、高级管理人员薪酬方案的公告 | 2026-04-27 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39769092 | 上海天璇律师事务所关于四川梓橦宫药业股份有限公司2026年第二次临时股东会的法律意见书 | 2026-04-27 | Chinese | ||
| 39769050 | 2025年度独立董事述职报告（程志鹏） | 2026-04-27 | Chinese | ||
| 39769030 | 2025年度独立董事述职报告（黄元林） | 2026-04-27 | Chinese | ||
| 39769016 | 关于召开2025年年度股东会通知公告（提供网络投票） | 2026-04-27 | Chinese | ||
| 39769008 | 2025年度内部控制评价报告 | 2026-04-27 | Chinese | ||
| 39768994 | 关于2026年董事、高级管理人员薪酬方案的公告 | 2026-04-27 | Chinese | ||
| 39768982 | 平安证券股份有限公司关于四川梓橦宫药业股份有限公司2025年度募集资金存放、管理和实际使用情况的专项核查报告 | 2026-04-27 | Chinese | ||
| 39768964 | 2025年年度报告 | 2026-04-27 | Chinese | ||
| 39768890 | 关于2026年第二次临时股东会延期公告 | 2026-04-15 | Chinese | ||
| 39768888 | 关于使用自有闲置资金委托理财的进展公告 | 2026-04-14 | Chinese | ||
| 39768880 | 第四届董事会第十九次会议决议公告 | 2026-04-09 | Chinese | ||
| 39768875 | 关于2025年年度报告延期披露的提示性公告 | 2026-04-09 | Chinese | ||
| 39768865 | 独立董事变动公告 | 2026-04-09 | Chinese | ||
| 39768858 | 独立董事提名人声明与承诺 | 2026-04-09 | Chinese | ||
| 39768851 | 关于召开2026年第二次临时股东会通知公告（提供网络投票） | 2026-04-09 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
梓橦宫 via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58866/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58866 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58866 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58866 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58866}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 梓橦宫 (id: 58866)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.